Flinton Capital Management’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Flinton Capital Management’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-7,760	Closed	-$418K	–	874
2017 Q4	$418K	Buy	7,760 +1,664	+27%	+$91K	0.01%	474
2017 Q3	$348K	Sell	6,096 -1,840	-23%	-$108K	0.01%	474
2017 Q2	$477K	Buy	7,936 +4,960	+167%	+$282K	0.02%	394
2017 Q1	$162K	Buy	+2,976	New	+$147K	0.01%	539

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Flinton Capital Management's BIVV Position: Q1 2018 in Review

Flinton Capital Management sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 7,760 shares — an estimated $418K sold.

Flinton Capital Management first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $477K in Q2 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

Flinton Capital Management reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Flinton Capital Management sold 7,760 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $418K.
Flinton Capital Management first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
Flinton Capital Management's Bioverativ Inc. Common Stock position peaked at $477K in Q2 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Flinton Capital Management's 13F filing for Q1 2018, filed 10 May 2018.